Curious to see your top suppliers emissions?
Book a demo for a pilot project
Junshi Biosciences
Pharmaceutical Preparation ManufacturingChinaPNK: SHJBF
Last verified 10 months agojunshipharma.com
Junshi Biosciences, also known as Junshi Pharmaceutical, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in China (CN). Founded in 2012, the company has rapidly established itself as a leader in the development of innovative biopharmaceuticals, focusing on immuno-oncology and other therapeutic areas.
With a strong operational presence across major regions in China and expanding globally, Junshi Biosciences is dedicated to delivering cutting-edge treatments that address unmet medical needs. Its core products, including monoclonal antibodies and targeted therapies, are distinguished by their unique mechanisms of action and commitment to patient-centric solutions.
Recognised for its significant contributions to the biopharmaceutical landscape, Junshi Biosciences continues to enhance its market position through strategic partnerships and a robust pipeline of clinical candidates, solidifying its reputation as a forward-thinking innovator in the industry.
39
DitchCarbon score
-3 vs industry average
Junshi Biosciences’s score of 39 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Junshi Biosciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Junshi Biosciences's reported carbon emissions
Junshi Biosciences, a Pharmaceutical Preparation Manufacturing company headquartered in China, reported its estimated carbon emissions for 2025 at approximately 1,184,920,000 kg CO2e. This total includes 142,772,000 kg CO2e from Scope 1, 196,309,000 kg CO2e from Scope 2, and 845,849,000 kg CO2e from Scope 3. In the preceding year, 2024, the company's estimated emissions were about 1,171,177,000 kg CO2e, comprising 189,530,000 kg CO2e from Scope 1, 114,655,000 kg CO2e from Scope 2, and 866,992,000 kg CO2e from Scope 3. Emissions data are sourced directly from Shanghai Junshi Biosciences Co., Ltd. Junshi Biosciences has not disclosed specific climate reduction targets or commitments, nor does it participate in initiatives such as SBTi or Climate Pledge.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Junshi Biosciences’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Junshi Biosciences yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Junshi Biosciences10 months ago
39
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more